Colgate-Palmolive (NYSE:CL) Shares Bought by Zevin Asset Management LLC

Zevin Asset Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL) by 2.3% in the third quarter, HoldingsChannel.com reports. The firm owned 63,563 shares of the company’s stock after buying an additional 1,451 shares during the quarter. Colgate-Palmolive makes up 1.5% of Zevin Asset Management LLC’s holdings, making the stock its 25th biggest holding. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $4,673,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Colgate-Palmolive by 1.4% in the second quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock valued at $5,482,958,000 after purchasing an additional 1,056,530 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Colgate-Palmolive by 0.5% during the second quarter. BlackRock Inc. now owns 60,205,815 shares of the company’s stock worth $4,314,949,000 after buying an additional 279,887 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Colgate-Palmolive by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 20,354,779 shares of the company’s stock worth $1,458,828,000 after buying an additional 573,566 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Colgate-Palmolive by 201.8% during the second quarter. Invesco Ltd. now owns 8,642,044 shares of the company’s stock worth $619,374,000 after buying an additional 5,778,145 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Colgate-Palmolive by 16,117.1% during the second quarter. Nuveen Asset Management LLC now owns 6,435,107 shares of the company’s stock worth $461,204,000 after buying an additional 6,395,426 shares during the last quarter. Institutional investors own 76.09% of the company’s stock.

A number of equities analysts recently issued reports on CL shares. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating on the stock in a report on Monday, November 4th. Wells Fargo & Co raised their price objective on shares of Colgate-Palmolive from $68.00 to $70.00 and gave the company a “market perform” rating in a research report on Monday, July 29th. Piper Jaffray Companies started coverage on shares of Colgate-Palmolive in a research report on Tuesday, August 13th. They issued an “overweight” rating for the company. UBS Group reduced their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Finally, Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price objective for the company. in a research report on Monday, November 4th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $72.57.

NYSE:CL traded down $0.24 during mid-day trading on Friday, reaching $66.63. The stock had a trading volume of 3,082,162 shares, compared to its average volume of 3,535,509. The company has a debt-to-equity ratio of 43.94, a quick ratio of 0.25 and a current ratio of 1.03. The firm has a market capitalization of $57.34 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 5.24 and a beta of 0.73. Colgate-Palmolive has a twelve month low of $57.51 and a twelve month high of $76.41. The business has a 50 day simple moving average of $69.58 and a 200 day simple moving average of $71.58.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.01. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. The company had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.95 billion. During the same period last year, the firm earned $0.72 EPS. The company’s revenue for the quarter was up 2.2% on a year-over-year basis. As a group, sell-side analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $0.43 per share. The ex-dividend date is Tuesday, October 22nd. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.58%. Colgate-Palmolive’s payout ratio is 57.91%.

In other news, insider Prabha Parameswaran sold 4,221 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, September 11th. The shares were sold at an average price of $71.68, for a total transaction of $302,561.28. Following the completion of the sale, the insider now directly owns 16,793 shares in the company, valued at approximately $1,203,722.24. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Philip G. Shotts sold 8,919 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $71.05, for a total transaction of $633,694.95. Following the sale, the vice president now owns 50,399 shares of the company’s stock, valued at $3,580,848.95. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 193,361 shares of company stock valued at $13,722,098. Insiders own 1.14% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Trading Ex-Dividend Strategy

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Leave a Reply

Your email address will not be published. Required fields are marked *

*